Abdominal Imaging: Archives News of the month
Assessment of intrahepatic cholangiocarcinoma with LI-RADS in the high-risk population: MRI diagnosis and postoperative survival
Abdominal Imaging 4 min.
Intrahepatic cholangiocarcinoma (iCCA) is a highly lethal hepatobiliary malignancy with a poor prognosis and is the second most common primary liver cancer after hepatocellular carcinoma (HCC) [1]. It is of great importance to distinguish iCCA from HCC due to their distinct treatment strategy and prognosis...
Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for colorectal liver metastases: a case-control study
Abdominal Imaging 5 min.
Colorectal cancer (CRC) is a significant global health issue and a leading cause of cancer-related mortality [1]. Liver metastasis is common in CRC, impacting prognosis and treatment options. Accurate detection and characterization of liver metastases are crucial for optimal treatment planning, which...
Low-residue diet with oral nutritional supplements prior to colonoscopy improves the quality of bowel preparation: an endoscopist-blinded, randomized controlled trial
Abdominal Imaging 4 min.
Colorectal cancer (CRC) has been considered a public health problem because of its high incidence and mortality. According to the GLOBOCAN 2022 estimates, CRC accounts for approximately 9.6% of all new cancer cases and 9.3% of cancer-related mortality worldwide [1]. By 2040, it is predicted that the...
A short-term predictive model for disease progression in acute-on-chronic liver failure: integrating spectral CT extracellular liver volume and clinical characteristics
Abdominal Imaging 6 min.
Acute-on-chronic liver failure (ACLF) represents a spectrum of clinical syndromes arising in the context of chronic liver disease, marked by multi-organ failure and a heightened risk of short-term mortality [1]. ACLF exhibits an exceptionally high 90-day adverse progression incidence, with reported mortality...
Accuracy of Controlled Attenuation Parameter for Liver Steatosis in High-Risk Patients for MASLD Using MRI-Proton Density Fat Fraction as Reference Standard
Abdominal Imaging 5 min.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent hepatic disorder worldwide affecting nearly 30% of the overall adult population [1]. While simple hepatic steatosis is considered a benign condition, it harbors the potential of progressing to metabolic dysfunction-associated...
